Oramed Pharmaceuticals
ORMP
#9146
Rank
NZ$0.30 B
Marketcap
NZ$7.11
Share price
5.12%
Change (1 day)
72.39%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2026 (TTM): NZ$7.51

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ$7.87. In 2025 the company made an earnings per share (EPS) of NZ$2.79 an increase over its 2024 EPS that were of NZ-$0.87.

EPS history for Oramed Pharmaceuticals from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.51169.28%
2025NZ$2.79-418.75%
2024NZ-$0.87-442.86%
2023NZ$0.26-114.89%
2022NZ-$1.7120.51%
2021NZ-$1.4239.29%
2020NZ-$1.02-31.71%
2019NZ-$1.49-4.65%
2018NZ-$1.578.86%
2017NZ-$1.44-9.2%
2016NZ-$1.5929.85%
2015NZ-$1.228.06%
2014NZ-$1.135.08%
2013NZ-$1.083.51%
2012NZ-$1.04137.5%
2011NZ-$0.44-60%
2010NZ-$1.09-0%
2009NZ-$1.09-16.67%
2008NZ-$1.31-25%
2007NZ-$1.75700%
2006NZ-$0.22303.56%
2005NZ-$0.05418

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
NZ$7.19-8.66%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$3.61-54.15%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ-$9.46-220.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
NZ-$0.26-103.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
NZ$0.69-91.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel